The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Finance

Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127
Finance

Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127

JAN 14, 2020
Bayer and Azitra Partner to Harness the Human Skin Microbiome
Finance

Bayer and Azitra Partner to Harness the Human Skin Microbiome

JAN 10, 2020
Psomagen-Macrogen Consortium Acquires All Patents and Data From US Company uBiome
Finance

Psomagen-Macrogen Consortium Acquires All Patents and Data From US Company uBiome

JAN 3, 2020
RB and Evolve BioSystems Team Up to Advance Infant Gut Health
Biotics and Supplements

RB and Evolve BioSystems Team Up to Advance Infant Gut Health

DEC 10, 2019
Caelus Health and Nestlé Health Science sign exclusive global development & option agreement
Biotics and Supplements

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement

NOV 27, 2019
Cognate BioServices announces acquisition of Cobra Biologics
Finance

Cognate BioServices announces acquisition of Cobra Biologics

NOV 21, 2019
BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD
Finance

BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD

NOV 20, 2019
Arranta Bio announces the acquisition of Captozyme™, creating a Center for microbiome development and clinical supply
Finance

Arranta Bio announces the acquisition of Captozyme™, creating a Center for microbiome development and clinical supply

NOV 15, 2019
EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema
Finance

EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema

NOV 13, 2019
Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S
Biotics and Supplements

Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S

NOV 11, 2019
OraSure Technologies, Inc. Announces Purchase of Diversigen
Finance

OraSure Technologies, Inc. Announces Purchase of Diversigen

NOV 7, 2019